Kimberly-Clark Plans $48.8B Acquisition of Kenvue, Parent of Tylenol

• Kimberly-Clark is planning to borrow billions for the acquisition of Kenvue.
• The acquisition amount is set at $48.8 billion.
• Kimberly-Clark is holding investor calls ahead of a possible bond sale.
• The acquisition of Kenvue, the maker of Tylenol, is nearing its closing.
• The deal is expected to be finalized soon, with financial preparations underway.